Long-term use of benzodiazepines for anxiety remains a widespread, despite guidelines that recommend against it, according to a roundtable discussion at the annual conference of the Anxiety Disorders Association of America. Benzos alleviate anxiety symptoms, but do not resolve the disorder in the long term, with posttreatment relapse rates as high as 63%. Associated learning impairment “significantly diminishes the effects” of cognitive-behavioral therapy, said one speaker; “…the result is reduced anxiety in the moment but worse long-term anxiety reactions documented in both animal and human studies.”
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.
Mad in America has made some changes to the commenting process. You no longer need to login or create an account on our site to comment. The only information needed is your name, email and comment text. Comments made with an account prior to this change will remain visible on the site.